Edap Tms SA
NASDAQ:EDAP
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.41
8.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EDAP stock under the Base Case scenario is 7.54 USD. Compared to the current market price of 2.69 USD, Edap Tms SA is Undervalued by 64%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Edap Tms SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EDAP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Edap Tms SA
Balance Sheet Decomposition
Edap Tms SA
Current Assets | 78.5m |
Cash & Short-Term Investments | 43.5m |
Receivables | 19.2m |
Other Current Assets | 15.8m |
Non-Current Assets | 13.1m |
PP&E | 8.2m |
Intangibles | 2.4m |
Other Non-Current Assets | 2.5m |
Current Liabilities | 27.6m |
Accounts Payable | 18.4m |
Short-Term Debt | 2.5m |
Other Current Liabilities | 6.7m |
Non-Current Liabilities | 7m |
Long-Term Debt | 2m |
Other Non-Current Liabilities | 5m |
Earnings Waterfall
Edap Tms SA
Revenue
|
60.4m
EUR
|
Cost of Revenue
|
-36m
EUR
|
Gross Profit
|
24.4m
EUR
|
Operating Expenses
|
-44.2m
EUR
|
Operating Income
|
-19.8m
EUR
|
Other Expenses
|
-1.4m
EUR
|
Net Income
|
-21.2m
EUR
|
Free Cash Flow Analysis
Edap Tms SA
EUR | |
Free Cash Flow | EUR |
In the second quarter of 2024, the company achieved a record revenue of EUR 15.8 million, up 10.6% year-over-year. This growth was driven by a 63% year-over-year increase in U.S. Focal One HIFU procedures and significant placements in prestigious medical centers, including the City of Hope and Robert Wood Johnson University Hospital. Despite a net loss of EUR 6.1 million, the company's aggressive expansion and strategic placements suggest a promising future, with planned patient enrollments for its Phase I/II BPH clinical trial starting in September 2024.
What is Earnings Call?
EDAP Profitability Score
Profitability Due Diligence
Edap Tms SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Edap Tms SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
EDAP Solvency Score
Solvency Due Diligence
Edap Tms SA's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Edap Tms SA's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EDAP Price Targets Summary
Edap Tms SA
According to Wall Street analysts, the average 1-year price target for EDAP is 11.9 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.
Dividends
Current shareholder yield for EDAP is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
Contact
IPO
Employees
Officers
The intrinsic value of one EDAP stock under the Base Case scenario is 7.54 USD.
Compared to the current market price of 2.69 USD, Edap Tms SA is Undervalued by 64%.